Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
53 studies found for:    DEMENTIA, LEWY BODY
Show Display Options
RSS Create an RSS feed from your search for:
DEMENTIA, LEWY BODY
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting A Post-Marketing Clinical Study of Aricept in Patients With Dementia With Lewy Bodies (DLB)
Conditions: Dementia, Lewy Body;   Lewy Body Disease
Interventions: Drug: E2020;   Drug: Placebo
2 Enrolling by invitation Open-label Study of Nelotanserin in Lewy Body Dementia With Visual Hallucinations or REM Sleep Behavior Disorder
Conditions: Lewy Body Dementia;   Dementia With Lewy Bodies;   Parkinson's Disease Dementia;   Visual Hallucinations;   REM Sleep Behavior Disorder
Intervention: Drug: Nelotanserin
3 Recruiting Imaging Inflammation in Patients With Parkinson's Disease Dementia or Dementia With Lewy Bodies
Conditions: Diffuse Lewy Body Disease;   Dementia With Lewy Bodies;   Parkinson's Disease Dementia
Intervention: Drug: 11C-PBR28
4 Recruiting Study Evaluating Nelotanserin for Treatment of Visual Hallucinations in Subjects With Lewy Body Dementia
Conditions: Lewy Body Dementia;   Visual Hallucinations
Interventions: Drug: Nelotanserin;   Drug: Placebo
5 Completed
Has Results
A Study of E2020 in Patients With Dementia With Lewy Bodies (DLB), Followed by a Long-term Extension Phase
Condition: Dementia With Lewy Bodies (DLB)
Interventions: Drug: Donepezil 5 mg;   Drug: Donepezil 10 mg;   Drug: Donepezil matched placebo
6 Completed Memantine Versus Placebo in Parkinson's Disease Dementia or Dementia With Lewy Bodies
Conditions: Parkinson's Disease Dementia;   Dementia With Lewy Bodies
Interventions: Drug: Memantine;   Drug: Placebo
7 Completed Efficacy and Safety of Memantine for Parkinson's Disease Dementia (PDD) and Dementia With Lewy Bodies (DLB)
Conditions: Dementia Associated With Parkinson's Disease;   Dementia With Lewy Bodies
Interventions: Drug: Memantine;   Drug: Placebo
8 Completed
Has Results
"Pilot Study of Armodafinil in Patients With Dementia With Lewy Bodies"
Condition: Dementia With Lewy Bodies
Intervention: Drug: Armodafinil
9 Completed
Has Results
A Long-term, Extension Study of E2020 in Patients With Dementia With Lewy Bodies
Condition: Dementia With Lewy Bodies (DLB)
Intervention: Drug: E2020
10 Recruiting Study Evaluating RVT-101 in Subjects With Dementia With Lewy Bodies: The HEADWAY-DLB Study
Condition: Dementia With Lewy Bodies
Interventions: Drug: RVT-101 35 mg;   Drug: RVT-101 70 mg;   Drug: Placebo
11 Completed
Has Results
A Double-blind Study of E2020 (Donepezil Hydrochloride) in Patients With Dementia With Lewy Bodies (DLB) (Study E2020-J081-431)
Condition: Dementia With Lewy Bodies (DLB)
Interventions: Drug: 3 mg Donepezil hydrochloride;   Drug: 5 mg Donepezil hydrochloride;   Drug: 10 mg Donepezil hydrochloride;   Drug: Placebo
12 Completed Imaging of Vesicular Acetylcholine and Dopamine Transporters in Dementia With Lewy Bodies
Condition: Dementia With Lewy Bodies
Interventions: Other: Imaging with IBVM;   Other: Imaging with DATSCAN;   Behavioral: neuropsychological evaluation
13 Recruiting Effects of Nucleus Basalis of Meynert Stimulation on Cognitive Disorders in Dementia With Lewy Bodies
Condition: Dementia With Lewy Bodies
Intervention: Procedure: Electrical stimulation of the nucleus basalis of Meynert
14 Completed Donepezil Therapy and Changes of Symptoms and Glucose Metabolism in Patients With Dementia With Lewy Bodies (DLB)
Condition: Dementia With Lewy Bodies (DLB)
Intervention: Drug: Donepezil
15 Recruiting Post-marketing Surveillance of Donepezil Hydrochloride - Investigation of Long Term Safety and Efficacy of Aricept as Well as Its Proper Use Information in Patients With Dementia With Lewy Bodies (DLB).
Condition: Dementia With Lewy Body Disease
Intervention: Drug: Donepezil Hydrochloride
16 Completed Safety and Efficacy of Galantamine in Patients With Dementia With Lewy Bodies
Condition: Lewy Body Disease
Intervention: Drug: Galantamine
17 Recruiting Construction-LBD (Constructional Apraxia in Alzheimer's Disease (AD) and Lewy Body's Dementia (LBD))
Conditions: Alzheimer's Disease;   Lewy Body's Dementia
Interventions: Other: Rey figure test;   Other: MRI
18 Completed Diagnostic of Lewy Body Dementia by Combining Scintigraphy (SPECT) Using a Specific Transporter and Magnetic Resonance Imaging (MRI)
Condition: Lewy Body Dementia
Intervention: Procedure: Single photon emission computed tomography and Magnetic Resonance Imaging
19 Recruiting Deep Brain Stimulation for Patients With Dementia With Lewy Bodies
Condition: Dementia With Lewy Bodies
Interventions: Procedure: Bilateral Nucleus Basalis Meynert DBS;   Procedure: Sham Nucleus Basalis Meynert DBS
20 Active, not recruiting Treadmill Walking in Individuals With Dementia With Lewy Bodies and Huntington's Disease
Conditions: Huntington Disease;   Lewy Body Disease
Intervention: Other: Treadmill Walking

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years